9
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Hospital El Salvador: a novel paradigm of intensive care in response to COVID-19 in central America

      discussion

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          On March 18, 2020, the first case of COVID-19 was confirmed in El Salvador. 1 Closely monitoring pandemic trends worldwide,2, 3, 4 local experts realised that if El Salvador's cases were to mirror global trends, 20% of people infected with severe acute respiratory syndrome coronavirus 2 would require hospitalisation, and between 5% and 8% would require an ICU bed. 5 Yet there were only 94 ICU beds in the public health system, distributed between nine hospitals (1·45 ICU beds per 100 000 people). By March 18, the occupancy rate was already 80%, meaning that only 19 ICU beds were available for critically ill patients with COVID-19 across the country. The profound risk associated with this low bed capacity was highlighted by experiences in Italy, which has 8·42 ICU beds per 100 000 people, 6 and yet still had a massive stress put on its health-care system when demand surpassed supply during an early surge of cases of COVID-19. To avert the upcoming crisis, it was urgent to increase ICU bed capacity and the reach of critical care spe-cialists. After multiple consultations with public health officials and international agencies, the government decided to build an entirely new hospital exclusively for patients with COVID-19: Hospital El Salvador. Creating Hospital El Salvador represents a unique approach, as most countries in the region opted to set up temporary hospitals. Hospital El Salvador was built using the existing infrastructure of the International Center for Fairs and Conventions of El Salvador. The hospital used two of the convention centre's pavilions for hospital beds, two for administration, and two for warehouses. The hospital has three emergency entrances for patients referred from different hospitals across the entire health care system. It also has two 15 000-gallon oxygen tanks to ensure oxygen supply to the remodelled pavilions. A negative pressure pavilion was set up to remove infectious particles from the ICU. Each ICU bed was fitted with a vital signs monitor, access to continuous oxygen flow, and a high-flow-capacity ventilator. The beds in both pavilions are monitored through cameras with a fibre optic connection, which feed images to the central monitoring hub at the hospital. The monitoring hub is based on pilot work done at the original COVID-19 care hospital in El Salvador: San Rafael Hospital. San Rafael had only three staff trained in critical care and three residents in training, and that human resource capacity quickly proved insufficient. Thus, the intensive care team and administrators at San Rafael completely reorganised the ICU, developing a telemedicine-based ICU patient monitoring system with cameras, open-source digital platforms, and phones so that intensive care clinicians could direct internal operations from a distance. Through the video monitoring system, one single intensive care physician could supervise the medical staff in the entire ICU area. The monitoring system would also reduce specialists' infection risk. Test results and patient observations were entered into a dedicated form from which risk scores and indices (APACHE score, risk of death, neutrophil to lymphocyte ratio, and others) could be calculated. A traffic light triage system was then developed. These data were linked to other public network hospitals, allowing critical care specialists to exchange patient management information in real-time. By May, 2020, COVID-19 cases were growing exponentially in El Salvador. In response, Hospital El Salvador construction progressed in phases; by June, 105 new ICU beds were made available, more than doubling the country's existing capacity. Additionally, San Rafael Hospital's multidisciplinary team was transferred to the new Hospital El Salvador. By July, 2020, another 143 intermediate care beds were opened, which could be converted into ICU beds if the need arose. When the first wave of the pandemic reached over 400 cases on July 22, these added ICU and intermediate care beds had a crucial role in preventing the public system from overflowing. Based on the pilot telemedicine model, 18 critical care specialists and 25 internal medicine physicians monitored 105 ICU beds and 143 intermediate care beds 24 h per day, through high resolution pan–tilt–zoom camera systems, with access to all vital signs and overall state of patients (figure ). These physicians communicated with 318 front-line general practitioners (157 in the ICU and 161 in intermediate care) and with 492 nurses (251 in ICU and 241 in intermediate care) following indications from the central hub at the hospital. These physicians were physically located at Hospital El Salvador and communicated with front-line health-care providers. Figure Patient monitoring using telemedicine Photo by Gabriela Galdamez, Hospital El Salvador. Hospital El Salvador was the first hospital with a negative pressure ICU in El Salvador and currently has 200 high-flow nasal cannulae (HFNC) machines. Pioneering this type of respiratory support in the country was a vital addition to patient care as HFNC might delay the need for intubation or ventilator use. In addition to the ICU and intermediate care beds, Hospital El Salvador added 731 hospital beds to care for patients with stable COVID-19. These beds can also be transformed into ICU beds if needed. Hospital El Salvador protocols were developed thanks to the support of medical experts in El Salvador, and from the Salvadoran diaspora that joined efforts with an international professional network. Equipment, infrastructure, and clinical staff training efforts were possible thanks to the solidarity of the Japan International Cooperation Agency and the United States Agency for International Development, among others. We were motivated to write this Comment after reading Richard Horton's Offline. 7 We are grateful for our courageous health-care workers and international allies. Precarious pre-COVID-19 conditions in our health system did not stop us. We remain vigilant, as we are aware of the long road ahead.

          Related collections

          Most cited references3

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

          Summary Background A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients. Methods All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan. We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing. Data were obtained with standardised data collection forms shared by WHO and the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. Researchers also directly communicated with patients or their families to ascertain epidemiological and symptom data. Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not. Findings By Jan 2, 2020, 41 admitted hospital patients had been identified as having laboratory-confirmed 2019-nCoV infection. Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]). Median age was 49·0 years (IQR 41·0–58·0). 27 (66%) of 41 patients had been exposed to Huanan seafood market. One family cluster was found. Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum production (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38). Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8·0 days [IQR 5·0–13·0]). 26 (63%) of 41 patients had lymphopenia. All 41 patients had pneumonia with abnormal findings on chest CT. Complications included acute respiratory distress syndrome (12 [29%]), RNAaemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died. Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα. Interpretation The 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality. Major gaps in our knowledge of the origin, epidemiology, duration of human transmission, and clinical spectrum of disease need fulfilment by future studies. Funding Ministry of Science and Technology, Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technology Commission.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Preparing for COVID-19: early experience from an intensive care unit in Singapore

            Dear Editor, About a third of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) become critically ill and require intensive care unit (ICU) admission [1]. As the COVID-19 (coronavirus disease-19) outbreak spreads [2], ICUs outside of China need to prepare for a potential surge of critically ill patients and counter the high transmissibility of SARS-CoV-2 [3]. Liu et al. have described their important preparations [4], and we would like to expand on their good advice by sharing lessons learnt from our early experience. By 17 February 2020, Singapore recorded the highest number of confirmed cases outside of mainland China with several clusters of local transmission. All healthcare institutions adopted a common strategy of containment, with isolation of all suspected or confirmed cases of COVID-19 in negative-pressure rooms. We were fortunate that most ICU beds were single rooms—this infrastructure was put in place following the outbreak of SARS in 2003. We realized preparing ICUs for patients with COVID-19 had numerous other requirements. First, infection control not only involved strict adherence to personal protective equipment for the individual, but also involved changes in group dynamics. We organized our ICU to mitigate the effects of any infected staff by avoiding potential spread between teams (see Table 1). Related to infection control, the medical ICU was given the task to cohort suspect or confirmed cases, including with peri- and post-partum care of pregnant women. Second, evolving information necessitated rapid and regular communications with large, disparate groups of clinicians. Table 1 Critical care issues and solutions for COVID-19 Issues Principles Solutions Infection control 1. Avoidance of cross-contamination among HCW 2. Education and re-education on personal protective equipment and use of powered air-purifying respirators 3. Provision for workflows to cater to special groups, such as pregnant women with acute respiratory illness who are in labour 4. Enhanced surveillance for infection in HCW 5. Strong emphasis on good hand hygiene for all 6. Robust visitor screening and management • A dedicated roster to segregate “clean” and isolation teams, and to provide for stand-bys • Provision of clean scrubs for HCW to change into before duty; showering facilities at the end of shift • Education and re-education on personal protective equipment and use of powered air-purifying respirators, especially for isolation teams • Allow isolation teams to have a 2-week off-duty observation period (“wash-out” period), after every period of ward cover if manpower allows • Mandatory reporting of twice daily temperature monitoring by all HCW • Advance declaration of leave and overseas trips by HCW • Screening questions are regularly updated as case definitions evolve over time, especially for known clusters of infection in the community • Provision of thermal scanners at the doorstep to screen for fever • Maintaining a hospital visitor log to allow for contact tracing and activity mapping of confirmed cases Dissemination of information to HCW 1. Robust system of dissemination of information (changing policies, workflows, etc.) 2. Email and meetings alone are insufficient to operationalize urgent changes on the ground 3. Clinical discussions of confirmed cases within the ICU community • Utilization of secure and approved platforms such as institutional email and messaging applications to inform various job groups and teams of rapidly evolving workflows and policies • Utilization of secure videoconferencing applications to hold inter-institution and inter-department meetings and educational sessions • Utilization of secure and approved applications such as messaging and videoconferencing applications to conduct clinical discussions of cases and the sharing of experience Resuscitation and code blue response 1. Provide clear guidelines on personal protective equipment and use of powered air-purifying respirators in ISO wards and normal wards during resuscitation 2. Provide inter-professional simulation of resuscitation scenarios for suspected or confirmed cases • Simulation practice with personal protective equipment and use of powered air-purifying respirators will help identify gaps in the wards and prepare ISO teams for such scenarios • Simulation with limited team members per scenario, for example, 4 members per team, to allow acclimatization of HCW to perform resuscitation in smaller teams • Checklists for preparation of drugs and pre-prepared trolleys for equipment, for intubation, line setting and other procedures, to minimize staff movement and enhance efficiency • Creative ways to improve communications during resuscitation, such as utilization of a printed “Call Airway Team” card for difficult intubations, using a communication whiteboard in the patient room and using walkie-talkies to relay messages to staff outside the room for equipment and help Advanced ICU services 1. To provide clear thresholds for transfers of deteriorating cases for ECMO 2. To provide efficient and safe delivery of ICU bronchoscopy • Early transfer of deteriorating cases is recommended. Provision of thresholds for transfer and workflows for non-ECMO centres • Use of disposable bronchoscopes for bronchoscopy and percutaneous tracheostomy Psychological stress and burnout of HCW 1. To provide emotional support, encouragement and appreciation to HCW 2. Reduce stigmatization of HCW by ill-informed members of the public • Special provision of meals and drinks to boost morale; laundry service for used scrubs • Provision of regular updates of the local situation and status by the government and institution leadership • Frequent encouragement of HCW by divisional heads and senior leaders via emails, messaging apps and social media platforms, allowing staff to remain engaged • Timely articles and courageous stories of frontline staff • Appropriate media coverage of HCW at the frontline to increase empathy and reduce stigmatization ECMO extracorporeal membrane oxygenation, HCW healthcare workers, ICU intensive care unit Third, we had to train non-ICU acute medical staff dealing with critically ill patients prior to ICU admission, especially for resuscitation. Fourth, we had to re-examine specific ICU services. Given that extracorporeal membrane oxygenation (ECMO) for severe viral pneumonia is well-established [5], we prepared to cohort all COVID-19 patients in the medical ICU and have a satellite team from the cardiothoracic ICU manage the ECMO circuit. Lastly, we realized staff morale took an early hit due to multiple factors, including increased workload due to implementation of strict infection control measures, uncertainty over the effectiveness of personal protective equipment, anxiety over the lethality of any infection, concern for the well-being of their family members and stigmatization by members of the public. To address the various issues of infection control, information flow, resuscitation training, advanced ICU services and psychological well-being of staff, we formulated several principles and solutions, which we hope can help other ICUs prepare for COVID-19 (see Table 1).
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Offline: Reasons for hope

              Fatigue. Despair. Misery. Cracks are beginning to appear in our mental resilience. 10 months of this calamity. How much more can we bear? It was always so. When the Bishop of Winchester died of plague in 1626, John Milton issued a searing cry of anguish in his Elegia Tertia. The great poet was just 17 years old, “sad...with no companion, and many sorrows clung to my soul”. He sought to commemorate this “grim killing” of a revered literary figure, a “dreadful death, fearsome with her sepulchral torch”. “Why does it please you”, Milton asked, “to stain your hands with human slaughter, and to have sharpened sure arrows against a noble breast, and to have driven a half-divine soul from its home?” It would be easy to sink into despondency. Governments are struggling. The public is restless. We need hope. There was one buoyant piece of news last week. The UK's National Health Service (NHS) committed itself to becoming the world's first carbon net zero health system by 2040. WHO's Director-General, Tedros Adhanom Ghebreyesus, welcomed the news, noting that “Health is leading the way to a greener, safer planet.” The NHS has appointed Nick Watts, who has blazingly led The Lancet's Countdown on Health and Climate Change, as its first Chief Sustainability Officer. This news is certainly one reason for hope. © 2020 Nick Watts 2020 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. There are more. As Laura Spinney pointed out in her history of the 1918 influenza pandemic, Pale Rider (2017), humanity was left transformed once the infection ebbed. Out of tragedy came regeneration. “The 1918 pandemic accelerated the pace of change in the first half of the twentieth century, and helped shape our modern world.” Societies bounced back. The 1920s ushered in a new era of intellectual and artistic creativity. Governments embraced health and made it an explicit political priority—“The state of a nation's health came to be seen as an index of its modernity or civilisation.” The conditions for universal health care were created. There was a “psychological shift” across the world. Although we are still in the midst of a dreadful coronavirus syndemic, if we lift our gaze we can see a better future ahead, a future that is up to us to define. Our societies can revive, stronger, smarter, and kinder. The first step is to reinvigorate our conversation about what tomorrow should look like. That conversation has started. Fran Baum and Sharon Friel recently proposed the need for a social as well as a biological vaccine to solve the challenge of COVID-19. They argued in the Medical Journal of Australia that we need to go beyond a biomedical vision for solving this syndemic. By a social vaccine, they mean “a metaphor designed to shift the dominant biomedical orientation of the health sector towards the underlying distal factors that cause disease and suffering”. They set our four foundational requirements for health—a life with security, opportunities that are fair, a planet that is habitable and supports biodiversity, and governance that is just. Each of these requirements determines the components of a social vaccine. A life with security demands a universal system to guarantee social protection, employment, and shelter; progressive taxation; and international treaties to ensure peace and security. Opportunities that are fair include (at a minimum) universal and free education; racial, sex, and disability discrimination laws; decent jobs; and environments that enable healthy choices. A planet that is habitable requires a zero carbon future; protection of biodiversity; and elimination of fossil fuel subsidies. Finally, governance that is just means a universal franchise; robust systems of political accountability; and strong civil society organisations, protected by legislation. They write, inspiringly, that, “A global social vaccine will enable a new way of living that is healthy, just, convivial, and sustainable, and will inoculate future society against a return to a world growing increasingly less healthy, sustainable, and equal.” Or turn to Rene Loewenson and colleagues who wrote a powerful call to reclaim a comprehensive public health in BMJ Global Health last month—“Biosecurity is not equal to public health”, they insisted. Something is stirring in the heart of our society. In health, the debate about our future is intensifying. Old assumptions are being questioned. New directions are being proposed. Amid the carnage of COVID-19, a renaissance of hope is emerging. It's time to join the conversation about the world to come. © 2020 Flinders University 2020 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. © 2020 Australian National University 2020 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. © 2020 Health Systems Global 2020 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
                Bookmark

                Author and article information

                Journal
                Lancet Glob Health
                Lancet Glob Health
                The Lancet. Global Health
                The Author(s). Published by Elsevier Ltd.
                2214-109X
                23 December 2020
                23 December 2020
                Affiliations
                [a ]El Salvador Hospital, San Salvador, El Salvador
                [b ]81 y 83 Centro Médico Escalón, San Salvador, El Salvador
                [c ]Ministry of Health of El Salvador, San Salvador, El Salvador
                [d ]Basic Health International, San Salvador, El Salvador
                [e ]National Institute of Health, San Salvador, El Salvador
                [f ]Center for Global Health, Colorado School of Public Health, Aurora, CO 80045, USA
                [g ]Department of Surgery and Emory Critical Care Center, Emory University, Atlanta, GA 30322, USA
                Article
                S2214-109X(20)30513-1
                10.1016/S2214-109X(20)30513-1
                7834343
                33357501
                bdb50e9c-8594-40ac-9463-54bdb9d3b7e4
                © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                Categories
                Comment

                Comments

                Comment on this article